Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. April 2025 08:05 ET | Quelle: Scienture Holdings, Inc.

SCIENTURE announces the divestiture of its legacy subsidiaries for a total consideration of $5 million and dedicates its full focus to the Branded and Specialty Pharma segment through Scienture, LLC.

TAMPA, FL, April 08, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on...
18. März 2025 08:05 ET | Quelle: Scienture Holdings, Inc.

SCIENTURE announces the U.S. FDA Approval of its NDA for SCN-102, to be launched as ArbliTM, (losartan potassium) Oral Suspension, 10mg/mL. The global market for losartan potassium was approximately $1.5 billion in sales in 2024.

TAMPA, FL, March 18, 2025 (GLOBE NEWSWIRE) -- – SCIENTURE HOLDINGS, INC. NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced...
01. Februar 2021 16:05 ET | Quelle: Trxade Group, Inc.

Trxade Group to Postpone Virtual Roadshow Presentation

TAMPA, FL, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (MEDS) an integrated drug procurement, delivery and healthcare platform, today announced that it will postpone its virtual roadshow,...
15. Juli 2020 08:00 ET | Quelle: Trxade Group, Inc.

Trxade Group to Report Second Quarter 2020 Results of Operations on Monday, July 27, 2020

TAMPA, FL, July 15, 2020 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (MEDS) an integrated drug procurement, delivery and healthcare platform, announced today that it plans to release its financial...